Patent · US Active

Antibodies targeting B-cell maturation antigen and methods of use

US11725059B2 · kind B2 · utility

2Cited by
16References
40Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 11, 2021
Grant dateAug 15, 2023
Priority date
Expiry dateOct 21, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70578
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The presently disclosed subject matter provides antibodies that bind to B-cell maturation antigen (BCMA) and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.